News
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
Onco-Innovations partners with University of Alberta and Cross Cancer Institute for preclinical study focusing on hard-to-treat cancers, starting with glioblastoma. Research led by Dr. Michael Weinfeld -
-
-
-
-
-
-
-